News
Q1 2025 Earnings Conference Call April 29, 2025 8:30 PM ETCompany ParticipantsRobin Halpern - VP, Head of IRJames Quincey ...
President Donald Trump signed an Executive Order (EO) entitled “Transparency Regarding Foreign Influence at American ...
Despite persistent supply chain issues and other challenges, long-term trends favor composites in new platforms. Meanwhile, ...
19hon MSNOpinion
Restrictions on the export of rare earths are the sharpest sword China can wield,” Harald Elsner of the German Raw Materials ...
They’re young, politically ambitious, and probably better at TikTok than you. This General Election there are 15 new ...
For years, Robert F. Kennedy Jr. has believed that childhood vaccines cause autism, and he’ been sharing such claims with everyone who would listen—from readers of Rolling Stone to strangers he ...
The study, which in part explores American hesitancy with trying new food, finds that leaning on seaweed as an ingredient in different snacks and making ready-to-eat dishes could sway consumers to the ...
Champion Iron Limited (TSX: CIA) (ASX: CIA) (OTCQX: CIAFF) ("Champion" or the "Company") reports production results ...
At this time, I'd like to welcome everyone to the Coca-Cola Company's first-quarter 2025 earnings results conference call. Today's call is being recorded. (Operator Instructions) I would like to ...
David Denton; Executive Vice President, Chief Financial Officer; Pfizer Inc Aamir Malik; Executive Vice President, Chief US Commercial Officer; Pfizer Inc Alexandre De Germay; Executive Vice President ...
6h
Sportschosun on MSNLee Jung-hoo's timely hit explosion of MLB team Lee Jung-hoo, hits in six consecutive games, and 17 RBIs in the season SF 45 SD (6th inning)San Francisco Giants Lee Jung-hoo hit a timely hit and continued his hit streak for six consecutive games. Lee Jung-hoo ...
21h
The Manila Times on MSNKiniksa Pharmaceuticals Reports First Quarter 2025 Financial Results and Recent Portfolio ExecutionLONDON, April 29, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) (Kiniksa), a biopharmaceutical company developing and commercializing novel therapies for diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results